BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10392429)

  • 1. [The biological basis for the use of polyunsaturated fatty acids of the omega-3 family in the prevention of atherosclerosis].
    Titov VN
    Vopr Pitan; 1999; 68(3):34-41. PubMed ID: 10392429
    [No Abstract]   [Full Text] [Related]  

  • 2. Omega-6 and omega-3 essential fatty acids in atherosclerosis.
    Horrobin DF
    Semin Thromb Hemost; 1993; 19(2):129-37. PubMed ID: 8356458
    [No Abstract]   [Full Text] [Related]  

  • 3. [Potential value of omega-3 polyunsaturated fatty acids in the prevention of atherosclerosis and cardiovascular diseases].
    d'Ivernois C; Couffinhal T; Le Métayer P; Haissaguerre M; Warin JF
    Arch Mal Coeur Vaiss; 1992 Jun; 85(6):899-904. PubMed ID: 1417409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Polyunsaturated fatty acids and atherosclerosis].
    Sorrentino M; Marini D; Troiani A; Pantaleoni GC
    Boll Chim Farm; 1991 Sep; 130(8):297-311. PubMed ID: 1801860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing.
    Bourre JM
    J Nutr Health Aging; 2004; 8(3):163-74. PubMed ID: 15129302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of omega 3 fatty acids. Atherosclerosis risk factor modification by omega 3 fatty acids.
    Weber PC; Leaf A
    World Rev Nutr Diet; 1991; 66():218-32. PubMed ID: 2053339
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prostaglandins and omega-3 acids in the prevention of atherosclerosis].
    Ribeiro L
    Arq Bras Cardiol; 1990 Apr; 54(4):279-81. PubMed ID: 2275631
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of n-3 fatty acids on atherosclerosis and the vascular response to injury.
    Goodnight SH
    Arch Pathol Lab Med; 1993 Jan; 117(1):102-6. PubMed ID: 8418754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Possible use of balneotherapy for atherosclerosis prevention].
    Antoniuk MV; Novgorodtseva TP
    Vopr Kurortol Fizioter Lech Fiz Kult; 2001; (6):3-5. PubMed ID: 11868532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids.
    Leaf A
    Fundam Clin Pharmacol; 2006 Dec; 20(6):525-38. PubMed ID: 17109646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-3 polyunsaturated fatty acids and inflammation in the arterial wall.
    Yaqoob P; Calder PC
    Eur J Med Res; 2003 Aug; 8(8):337-54. PubMed ID: 12915325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The prospects for using fish oil in preventing and treating dyslipoproteinemia and atherosclerosis].
    Kobaladze AS; Medulashvili GV
    Ter Arkh; 1990; 62(11):151-4. PubMed ID: 2094981
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of omega-3 fatty acids on cardiovascular health.
    Appel LJ
    Am Fam Physician; 2004 Jul; 70(1):34-5. PubMed ID: 15259519
    [No Abstract]   [Full Text] [Related]  

  • 14. [Atherosclerosis: feasibility of non-pharmacological correction of some risk factors].
    Enikeeva NA; Kitaĭskaia LS; Antoniuk MV
    Klin Med (Mosk); 1999; 77(3):25-8. PubMed ID: 10234942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Omega-3 unsaturated fatty acids: therapeutic applications].
    Aguilera J
    Ann Med Interne (Paris); 1994; 145(1):44-9. PubMed ID: 8192281
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of n-3 polyunsaturated fatty acids on the blood coagulation system].
    Petrukhina GN; Kalugin SA; Makarov VA
    Eksp Klin Farmakol; 1997; 60(1):76-88. PubMed ID: 9162295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention.
    Russo GL
    Biochem Pharmacol; 2009 Mar; 77(6):937-46. PubMed ID: 19022225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-3 and omega-6 fatty acids in the insulin resistance syndrome. Lipid and lipoprotein metabolism and atherosclerosis.
    Rustan AC; Nenseter MS; Drevon CA
    Ann N Y Acad Sci; 1997 Sep; 827():310-26. PubMed ID: 9329764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [N-3 polyunsaturated fatty acid in cardiovascular disease].
    Cybulska I
    Przegl Lek; 2006; 63(8):685-7. PubMed ID: 17441383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of monitoring and supplementation of omega 3 fatty acids in cystic fibrosis.
    Coste TC; Armand M; Lebacq J; Lebecque P; Wallemacq P; Leal T
    Clin Biochem; 2007 May; 40(8):511-20. PubMed ID: 17316592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.